INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 49 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $295,000 | +39.8% | 7,600 | 0.0% | 0.12% | +34.1% |
| Q1 2016 | $211,000 | -48.4% | 7,600 | 0.0% | 0.09% | -23.5% |
| Q4 2015 | $409,000 | -95.0% | 7,600 | -96.3% | 0.12% | -92.7% |
| Q3 2015 | $8,235,000 | -28.2% | 205,657 | -42.7% | 1.58% | +45.8% |
| Q2 2015 | $11,465,000 | +31.4% | 358,857 | -1.8% | 1.08% | +31.1% |
| Q1 2015 | $8,725,000 | +33.3% | 365,357 | -1.5% | 0.82% | +31.4% |
| Q4 2014 | $6,544,000 | +28.3% | 370,757 | -0.3% | 0.63% | +19.2% |
| Q3 2014 | $5,100,000 | -23.1% | 371,957 | -5.4% | 0.53% | -7.6% |
| Q2 2014 | $6,630,000 | -7.5% | 393,257 | -0.3% | 0.57% | -2.7% |
| Q1 2014 | $7,169,000 | – | 394,357 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
| Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
| DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
| Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
| Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
| Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |